glomerular filtration rate (eGFR) and body composition in patients with CKD and healthy people has previously been investigated [13, 14] . However, eGFR is based on estimates using plasma creatinine, which is dependent on muscle mass, thus creating a risk of inaccuracy when relating eGFR to muscle mass. To our knowledge, neither the association between body composition and measured GFR nor the association between strength and balance and their respective relationships to muscle mass has been examined in patients with CKD stages 3-5 not on dialysis.
Our aims are (i) to investigate the relationship between body composition and measured GFR in patients with an eGFR <30 mL/min/1.73 m 2 , (ii) to investigate the frequency of sarcopenia and (iii) to investigate the relationship between physical function (balance and strength) and body composition in these patients.
M A T E R I A L S A N D M E T H O D S
This study is part of the RENEXC (REN-kidney; EXC-exercise) trial (www.ClinicalTrials.gov; NCT02041156), a consecutive, prospective, randomized controlled and interventional exercise training study in patients with CKD not on renal replacement therapy.
The inclusion criteria were prevalent and incident patients with an eGFR <30 mL/min/1.72 m 2 , adults !18 years of age, all renal diagnoses and any number of comorbidities. The exclusion criteria were orthopedic impediment, severe neurological dysfunction, inability to understand patient information and answer health-related quality of life questionnaire, renal replacement therapy and estimated start of dialysis within 12 months of study start.
GFR estimation and measurement
To calculate eGFR we used the Modification of Diet in Renal Disease (MDRD) equation. To quantify measured GFR we used iohexol clearance [15, 16] . It was performed in a standardized manner at the Department of Clinical Chemistry, Laboratory Medicine Skåne, which is accredited by the Swedish Board for Accreditation and Conformity Assessment (SWEDAC) according to the international standards of International Organization for Standardization (ISO) 15189:2012.
Dual-energy X-ray absorptiometry (DEXA)
DEXA scanning was conducted in a standardized manner, according to procedures recommended by the manufacturer, at the Department of Diagnostic Radiology, Skåne University Hospital, which is accredited by SWEDAC according to ISO 15189:2012. The hospital changed from Lunar Prodigy to Lunar iDEXA during the study period. Lunar iDEXA is an upgrade from Lunar Prodigy and has a superior camera and gives a more precise measurement. The analysis software is the same as Lunar Prodigy. In all, 32 patients were analyzed with Lunar iDEXA.
Sarcopenia was defined as low muscle mass [17] , low muscle strength [18] or both [19] . An appendicular skeletal muscle index (ASMI) <7.3 kg/m 2 for men and <5.5 kg/m 2 for women was defined as low muscle mass [17] . Handgrip strength <30 kg for men and <20 kg for women was defined as low muscle strength [18] . For each indicator, cutoff values were greater than two standard deviations below the sex-specific means from a reference population (18-40 years old and 20-102 years old, respectively).
Functional reach
The patient stands positioned next to a wall but not touching it, the arm is extended at a 90 angle from the shoulder, fist closed and then is asked to reach forward as far as possible without losing balance. The distance between the starting point and end point of three successive trials is recorded and the mean registered [12] .
Berg Balance Test
The test comprises a set of 14 simple balance-related tasks with a full score of 56, ranging from being able to sit on a chair without back support to standing on one foot. The degree of success in achieving each task is given a score of 0 (unable) to 4 (independent) and the final measure is the sum of all the scores [12] .
Handgrip strength
Handgrip strength is measured in kilograms by a Jamar dynamometer, in a sitting position without back support with the elbow at a 90 angle and the arm close to the body. For each hand, the scores of three successive trials were recorded and the mean registered [12] .
Isometric quadriceps strength
Isometric quadriceps strength is tested by knee extension against resistance and evaluated in kilograms multiplied by centimeters using the distance from the knee to the ankle. For each leg, the scores of three successive trials were recorded and the mean registered [12] .
Comorbidity
The comorbidity of each patient was evaluated by the same clinician (M.H.) using the Davies comorbidity score [20] with seven different domains: malignancy, ischemic heart disease, peripheral vascular disease, left ventricular dysfunction, diabetes mellitus, systemic collagen vascular disease or other significant pathology (a condition severe enough to have an impact on survival in the general population). Hypertension was included in 'other significant pathology', as it has a significant impact on survival. We chose the ranking system as described by Davies; patients with a cumulative score of 0, 1-2 or >3 were classified as having a comorbidity rank of 0, 1 or 2, respectively.
Nutritional assessment
Each patient was prescribed continued normal protein intake, a restricted protein diet consisting of 0.8 or 0.6 g/kg body weight/day by their physician or referred to a specialized renal dietitian for dietary counseling. Subjective global assessment (SGA) [21] and protein catabolic rate (PCR) were used to describe the patients' nutritional status. PCR was calculated by the equation: 6.25 Â [(0.028 Â urine urea Â 24-h urine volume)
Statistical analysis
Descriptive statistics are presented as mean 6 standard deviation (SD) and/or median with interquartile range. Categorical variables were used to describe frequency and continuous variables for measurements. Data were analyzed using R software (R Foundation for Statistical Computing, Vienna, Austria). We chose the following references for practical reasons: female, 70 years old, with comorbidity classified as 1. These choices have no impact on the results, but were chosen to clarify and enable better understanding of the relationships between variables. Multiple linear regression analysis was performed to analyze the relationships between variables. The level of significance was set at P < 0.05.
R E S U L T S Patients
This study comprises 151 patients, 19-87 years of age (mean age 66 years). A total of 148 patients (98 men and 50 women) completed the measurements at baseline. Of these, three patients dropped out before baseline data measurement for acute medical reasons. The measured GFR ranged from 8 to 55 mL/min/1.73 m 2 , with an average of 22.5 6 8.2. Of special note is that eGFR underestimated actual GFR (measured GFR), thus explaining the discrepancy. [10 patients (7%) ]. The patients suffered from the following comorbidities: malignancy (14%), ischemic heart disease (20%), peripheral vascular disease (21%), left ventricular dysfunction (11%), diabetes mellitus (32%), systemic collagen vascular disease (11%) and other comorbidities (77%), for example, hypertension. The clinical characteristics of patients are presented in Table 1 . The characteristics of patients' nutritional status and physical function are presented in Table 2 .
Relationship between body composition and GFR, sex, age and comorbidity
In Table 3 , the analyses of body composition variables and body mass index (BMI) are given. Lean mass (P < 0.05), fat mass (P < 0.05), appendicular skeletal muscle (ASM) (P < 0.0001) and ASMI (P < 0.05) all showed significant positive relationships with GFR, but relative lean mass and relative fat mass did not. Lean mass, ASM, ASMI and relative lean mass were all significantly lower in women (P < 0.001), whereas fat mass (P < 0.05) and relative fat mass (P < 0.001) were significantly higher in women. Absolute values did not show significant relationships with age; however, relative lean mass was significantly and inversely related with age (P < 0.05) and relative fat mass related positively with age (P < 0.05). There was no significant relationship between body composition and comorbidity 0 or 2 (our reference is comorbidity 1).
BMI showed a significant positive relationship with GFR (P < 0.05). No significant relationship was observed with sex, age or comorbidity.
In our patients, a 1 mL/min/1.73 m 2 decrease of GFR was associated with a 0.15 6 0.07 kg decrease in lean mass, a 0.26 6 0.12 kg decrease in fat mass, a 0.12 6 0.03 kg decrease in ASM, a 0.03 6 0.01 kg/m 2 decrease in ASMI as well as a 0.11 6 0.05 kg/ m 2 decrease in BMI. We found that female sex, age and more comorbidities were associated with less lean mass and more fat mass.
Prevalence of sarcopenia
When we only used muscle mass, 54 (36%) patients were defined as having sarcopenia: 43 (44%) men and 11 (22%) women. When only using handgrip strength, 43 (29%) patients were defined as having sarcopenia: 25 (26%) men and 18 (36%) women. If both muscle mass and muscle strength were used, 20 (14%) patients were defined as having sarcopenia: 16 (16%) men and 4 (8%) women.
Relationship between balance and muscle strength and lean mass, sex, age and comorbidity
In Table 4 , the results for balance, measured as functional reach and Berg balance test, are given. Functional reach showed whereas the Berg balance test score showed a positive relationship with trunk lean mass (P < 0.05). Neither of them showed significant relationships with sex or comorbidity 0, but both showed significant relationships with age and comorbidity 2 (P < 0.001) (our reference is comorbidity 1). In our patients, a 1-kg increase in leg lean mass was associated with a 0.7 6 0.2 cm increase in functional reach and a 1-kg increase in trunk lean mass was associated with a 0.3 6 0.1 increase in the Berg balance test score. We found that age and the number of comorbidities were associated with worse balance in both tests. In Table 5 , the results for handgrip and quadriceps strength are given. Handgrip strength was significantly and positively related to arm lean mass as well as to sex. Isometric quadriceps strength was significantly positively related to leg lean mass and sex (P < 0.001). Moreover, significant inverse relationships were observed for age and comorbidity 2 (our reference is comorbidity 1). In our patients, a 1-kg increase of arm lean mass was associated with an 8 6 1.3 kg increase of handgrip strength in the right hand and an 8 6 1.4 kg increase in the left hand. For the legs, a 1-kg increase of leg lean mass was associated with a 113 6 18 kg-cm increase of isometric quadriceps strength in the right leg and a 122 6 18 kg-cm in the left leg. We found that female sex, age and number of comorbidities were associated with decreased strength. 
D I S C U S S I O N
In 148 patients with CKD stages 3-5, not on renal replacement therapy, we measured body composition and found that lean mass, ASM, fat mass, ASMI and BMI all showed positive significant relationships with GFR, especially ASM and ASMI after accounting for sex, age and number of comorbidities. This indicates that in in patients with CKD stages 3-5, ASM loss is strongly associated with a decline in GFR. Moreover, physical function was significantly related with muscle mass. Specifically, for balance, functional reach was positively associated with leg lean mass and the Berg balance test was positively associated with trunk lean mass. For strength, handgrip strength and isometric quadriceps strength were positively related with lean mass of the arms and legs, respectively. Another interesting result was that the prevalence of sarcopenia varied according to different indicators. However, no matter which indicator was used, sarcopenia was markedly more common in men than in women. Numerous previous studies have investigated the relationship between body composition and eGFR. Some of them illustrated that creatinine-based calculations of eGFR by both MDRD and Chronic Kidney Disease Epidemiology Collaboration are strongly impacted by lean mass [22, 23] . Cystatin C-based eGFR is also affected by body composition [24] . Some studies have suggested that age and lean mass are strong determinants of eGFR, especially in men [14] . An increase in fat mass has been shown to be associated with a decline in eGFR [25, 26] . All of these studies show that various estimates of GFR are dependent on body composition and thus can under-or overestimate actual GFR. Therefore, using eGFR can lead to a risk of inaccurate results concerning the relationship between body composition and kidney function, due to the muscle wasting prevalent in this patient group. We measured GFR and showed that loss of body mass was associated with a decline in GFR. To our knowledge, this is the first study to show a significant relationship between body composition and measured GFR in patients with CKD stages 3-5. The validity of these findings is strengthened by employing ASM and ASMI as measures of muscle mass. Other studies have suggested that high BMI might be a protective factor in patients with CKD or ESRD [27] [28] [29] [30] . Contrary to the general population, high BMI and larger body size are associated with lower mortality in these patients [27] [28] [29] [30] . In our study, BMI was positively associated with GFR.
Sarcopenia was defined by Rosenberg in 1988 [17] , referring specifically to involuntary loss of skeletal muscle mass and consequently, of strength. Sarcopenia is common in CKD [3, 13] and ESRD patients, especially after long-term dialysis or renal transplantation [31, 32] . It is associated with high mortality [33, 34] . However, there are an increasing number of studies suggesting that the definition of sarcopenia should include both muscle mass and muscle function [33, [35] [36] [37] [38] . We defined sarcopenia in our patients by using either ASMI or handgrip strength only, as well as both of them together [17] [18] [19] . The prevalence of sarcopenia was highest when using muscle mass only, lower when muscle strength only was used and lowest when both were employed. Many more men suffered from low muscle mass than women, whereas more women suffered from low muscle strength than men. However, when combining both low muscle mass and low muscle strength, sarcopenia in men was twice that of women. Thus men with CKD are more prone to loss of lean body mass than women and women are more prone to loss of muscle strength as kidney function declines.
We found evidence that body composition starts changing relatively early in the course of CKD rather than after initiation of dialysis, thus implying that recommendations for nutrition and exercise training need to be tailored according to level of kidney function in order to counteract loss of muscle mass and maintain balance and strength. Exercise training should aim at both appendicular and trunk skeletal muscle. An important question is whether exercise training administered during CKD stages 3-5 can affect the development of sarcopenia and reduce the risk of accidental falls. This is being studied in the interventional part of RENEXC.
Of special interest is our novel finding of a relationship between different balance functions and muscle mass. Accidental falls and fractures are common both in patients on maintenance hemodialysis and peritoneal dialysis [39] [40] [41] [42] [43] . There are a number of causes, including deranged calciumphosphate-vitamin D-parathyroid hormone homeostasis, osteoporosis, neuropathy, muscle weakness and general frailty [44] [45] [46] [47] [48] . In previous studies we have shown that balance was impaired in patients with CKD stages 3-5 and was a predictor for mortality after starting dialysis [12, 49] . In the present study, we found that balance was associated with lean mass: functional reach showed a significant relationship with lean mass of the legs and the Berg balance test with lean mass of the trunk. Consequently, in order to improve balance, both core exercises for the trunk and strength exercises for the legs should be part of the prescribed exercise training program. Moreover, we showed that limb muscle mass was strongly associated with limb strength, which is consistent with previous studies [7, 8, 10, 34] .
Some strengths of our study include, first, we used measured GFR instead of eGFR to avoid the influence of muscle mass on eGFR. Second, we used different methods and cutoff values to measure and define body composition and sarcopenia. Finally, physical function was defined by both balance and strength. Some limitations of our study are the average age of our patients was 66 years and 75% were >60 years old. Thus our results might be biased towards the aged CKD population. This could also be a strength, as the majority of patients with CKD are >60 years of age [50, 51] . Finally, because this is a baseline data analysis of a prospective trial, we cannot comment on longitudinal changes in body composition as GFR declines.
In conclusion, among patients with CKD stages 3-5, loss of lean body mass, especially ASM, was significantly related to GFR decline. Balance and strength were significantly related to muscle mass. Moreover, men were more prone to sarcopenia than women during kidney function decline. All these results provide a better understanding of changes in nutritional status with the decline of GFR in the CKD stages 3-5 population and have important implications for future studies about body composition, GFR, physical function and exercise training. 
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